Sino Biopharm (01177.HK) announced that on May 7, 2024, China Biopharmaceuticals Co., Ltd. made an announcement on the implementation of equity incentive plan for its subsidiary, Zhejiang Jingxin Tianqing Pharmaceutical Group Co., Ltd. ("Jingxin Tianqing"). From June 5, 2024 to June 13, 2024, the trustee purchased a total of 15.842 million shares of the company on the market according to the terms and conditions of the share incentive plan, which will be used for subsequent implementation of share incentives for selected participants.
中国生物制药(01177.HK)：正大天晴根股份激励计划购买股份
Sino Biopharm (01177.HK): SDIC Tianqing Pharmaceutical Co., Ltd. Incentive Plan Buys Shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.